Objectives: Safflower oils, which are sold commercially, are in demand with food, cosmetics, and health-promoting claims. In this study, safflower oil samples belonging to 11 different brands were evaluated in terms of European Pharmacopoeia Criteria 7.0. Additionally, in vitro weight control potential of all samples was investigated. Materials and Methods: Samples to be analyzed were purchased from pharmacies, herbal, online, and cosmetics stores. Acid and peroxide values of 11 safflower samples and analysis of their fatty acids by gas chromatography-mass spectrometry (GC-MS) were carried out according to the "Carthami oleum raffinatum" monograph registered in the European Pharmacopeia 7.0. To test the effects of all samples on weight control, their inhibitory effects on carbohydrate-digesting enzymes (alpha-glucosidase and alpha-amylase) were evaluated using spectrophotometric methods. Results: Out of 11 oil samples, only two of them had acid and peroxide values below the reference value. According to GC analysis, safflower oil samples are rich in monounsaturated fatty acids (oleic acid) and polyunsaturated fatty acids (linoleic acid) (67.10-99.53%) of total fatty acids in its content are oleic, linoleic, palmitic, and stearic acids. Saturated fatty acids were 0.58 to 12.18% of the total fatty acid methyl esters in oils. When evaluated in terms of the inhibition of alpha-amylase and alpha-glucosidase enzymes that hydrolyze carbohydrates, the results showed that safflower oil samples had no inhibitory activity on these enzymes. Conclusion: It has been determined in this report that many safflower oil samples on the market do not meet the quality criteria recommended in European Pharmacopoeia 7.0. It was observed that safflower oil did not show any inhibitory effect on these two enzymes, which is considered a rational approach for weight control.

Improving the quality of life in elderly patients and finding new treatment options for neurological diseases such as Alzheimer’s has become one of the priorities in the scientific world. In recent years, the beneficial effects and therapeutic properties of natural foods on neurological health have become a very remarkable issue. Walnut oil (WO) is a promising nutraceutical, with many phytochemicals and polyunsaturated fatty acids and is thought to be promising in the treatment of many neurological diseases and cognitive deficits, such as Alzheimer’s disease (AD). Polyphenolic compounds found in WO enhance intraneuronal signaling and neurogenesis and improve the sequestration of insoluble toxic protein aggregates. The objective of this study was to investigate the potential protective and therapeutic effects of WO in a model of AD induced by retinoic acid (RA) and brain-derived neurotrophic factor (BDNF). In order to achieve this, the experimental groups were formed as follows: Control group, WO group, Alzheimer’s disease (AD) group, AD + WO applied group (AD + WO). WO supplementation almost significantly reduced oxidative stress in the ad model, providing 2-fold protection against protein oxidation. Additionally, WO showed a significant reduction in tau protein levels (2-fold), increased acetylcholine (ACh) levels (12%), and decreased acetylcholine esterase (AChE) activity (~50%). Since it has been known for centuries that WO does show any adverse effects on human health and has neuroprotective properties, it may be used in the treatment of AD as an additional nutraceutical to drug treatments.

A simple, cost effective hydride generation atomic florescence spectrometry (HG-AFS) method was used for determination of total arsenic (As) in poultry and calf meat samples. The samples were digested in long necked glass digestion tubes using concentrated HNO3, HClO4 and H2SO4 as a mixture. The volume of acids (HNO3, HClO4) and the amount of sample to be used for digestion were optimized to achieve appropriate digestion. The accuracy of the proposed HG-AFS method was tested with certified reference material (DOLT 3 Dogfish Liver, NRC, Canada) and obtained results were in good agreement with certified value. The method limit of detection (LOD) value was calculated as 0.3 ng/g and dynamic range was 25 – 5000 pg/ml. Arsenic concentrations of poultry and calf meat samples were determined accurately by using aqueous calibration standards. Totally 31 samples (calf, chicken and turkey) obtained from local markets were analyzed. It was found that the average As concentration in calf meat (12.1 ± 3.9 ng/g) was significantly higher than the poultry samples whereas the arsenic concentrations were similar in turkey (3.1 ± 1.2 ng/g) and chicken (2.8 ± 1.1 ng/g) samples. In addition, dietary intake estimation of arsenic through consumption of calf and poultry meat was calculated and according to the gathered results daily intake of arsenic via calf meat was almost two times higher than poultry meat.

Almond oil marketed for health benefits and cosmetic purposes should be in compliance with the European Pharmacopoeia (EP) criteria. Therefore, in this study, 17 almond oil samples sold in pharmacies, herbal shops, online, and cosmetics stores were analyzed in terms of “almond oil” monograph criteria, which have been mentioned in EP 7.0. In this study, 17 almond oil samples sold in pharmacies, herbal, online, and cosmetics stores were analyzed in terms of “almond oil” monograph criteria, which have been mentioned in EP 7.0. Appearance, acidity value, and peroxide value of each sample were determined and the ingredients were identified by thin layer chromatography. Fatty acids were analyzed by gas chromatographic method using flame ionization detector. It was determined that two of the 17 samples complied with EP 7.0 criteria. Almond oil, which is currently marketed according to the manufacturer’s own marketing and quality criteria, is excluded from the Turkish Food Codex Standards. Our research has shown that most of the products do not comply with the EP standards. For this reason, it should be ensured that almond oil is listed in this codex and urgent arrangements should be made for quality control analysis.